Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · IEX Real-Time Price · USD
5.84
+0.11 (1.92%)
At close: Jul 19, 2024, 4:00 PM
5.79
-0.05 (-0.86%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Wave Life Sciences Revenue

Wave Life Sciences had revenue of $112.91M in the twelve months ending March 31, 2024, with 661.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.54M. In the year 2023, Wave Life Sciences had annual revenue of $113.31M with 3,005.10% growth.

Revenue (ttm)
$112.91M
Revenue Growth
+661.49%
P/S Ratio
6.33
Revenue / Employee
$421,321
Employees
268
Market Cap
715.25M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023113.31M109.66M3,005.10%
Dec 31, 20223.65M-37.32M-91.09%
Dec 31, 202140.96M20.89M104.03%
Dec 31, 202020.08M4.09M25.61%
Dec 31, 201915.98M1.57M10.89%
Dec 31, 201814.41M10.52M270.25%
Dec 31, 20173.89M2.80M256.50%
Dec 31, 20161.09M940.00K618.42%
Dec 31, 2015152.00K--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evolus 219.70M
Travere Therapeutics 183.23M
Weave Communications 178.08M
Sage Therapeutics 91.06M
Zymeworks 50.46M
Arbutus Biopharma 12.99M
Stoke Therapeutics 7.85M
Revenue Rankings